HCPCS A9607 is officially defined as "Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie." HCPCS A9607 is referenced in 2 tracked payer policy changes from BCBS Michigan and Nevada Medicaid. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS A9607 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.